跳至主要内容
临床试验/CTRI/2020/09/027654
CTRI/2020/09/027654已完成未知

A clinical study to evaluate the safety and feasibility of outpatient induction therapy in newly diagnosed adolescent and adult acute myeloid leukemia (AML). - AML Study

Tata Research Administrative Council TRAC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Newly diagnosed AML and high-risk myelodysplastic syndrome.
  • 2. Planned treatment with Cytarabine and daunomycin with or without midostaurin
  • 3. Normal organ function and no active infection in lungs
  • 4. Accommodation facility within one hour distance from hospital.

排除标准

  • 1. platelet count less than 10000 after 1 unit SDP transfusion
  • 2. Clinical internal/visceral bleeding manifestations like hematemesis, melaena, hematuria
  • 3. History of hypersensitivity/ allergy to blood/ blood products, chemotherapeutic drugs and antibiotics
  • 4. Acute medical emergencies like diabetic ketosis, diabetic ketoacidosis, hypertensive urgency/ emergency, acute kidney injury etc
  • 5. Relapsed AML case patients

研究者

发起方
Tata Research Administrative Council TRAC

相似试验